American Journal of Kidney Diseases
Volume 52, Issue 6 , Pages 1079-1083 , December 2008

Bleeding Complications After Transcutaneous Kidney Biopsy in Patients With Systemic Amyloidosis: Single-Center Experience in 101 Patients

  • Sandra M. Soares, MD

      Affiliations

    • Department of Internal Medicine, Mayo Clinic Rochester, Rochester, MN
    • ,
  • Fernando C. Fervenza, MD, PhD

      Affiliations

    • Division of Nephrology and Hypertension, Mayo Clinic Rochester, Rochester, MN
    • ,
  • Donna J. Lager, MD

      Affiliations

    • Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN
    • ,
  • Morie A. Gertz, MD

      Affiliations

    • Division of Hematology, Mayo Clinic Rochester, Rochester, MN
    • ,
  • Fernando G. Cosio, MD

      Affiliations

    • Division of Nephrology and Hypertension, Mayo Clinic Rochester, Rochester, MN
    • ,
  • Nelson Leung, MD

      Affiliations

    • Division of Nephrology and Hypertension, Mayo Clinic Rochester, Rochester, MN
    • Corresponding Author InformationAddress correspondence to Nelson Leung, MD, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55902

Received 15 December 2007 ,Accepted 9 May 2008.

References 

  1. Korbet SM. Percutaneous renal biopsy. Semin Nephrol. 2002;22:254–267
  2. Kovalik EC, Schwab SJ, Gunnells JC, Bowie D, Smith SR. No change in complication rate using spring-loaded gun compared to traditional percutaneous renal allograft biopsy techniques. Clin Nephrol. 1996;45:383–385
  3. Fraser IR, Fairley KF. Renal biopsy as an outpatient procedure. Am J Kidney Dis. 1995;25:876–878
  4. Parrish AE. Complications of percutaneous renal biopsy: A review of 37 years' experience. Clin Nephrol. 1992;38:135–141
  5. Prakash J, Singh M, Tripathi K, Rai US. Complications of percutaneous renal biopsy. J Indian Med Assoc. 1994;92:395–396
  6. Song JH, Cronan JJ. Percutaneous biopsy in diffuse renal disease: Comparison of 18- and 14-gauge automated biopsy devices. J Vasc Interv Radiol. 1998;9:651–655
  7. Preda A, Van Dijk LC, Van Oostaijen JA, Pattynama PM. Complication rate and diagnostic yield of 515 consecutive ultrasound-guided biopsies of renal allografts and native kidneys using a 14-gauge Biopty gun. Eur Radiol. 2003;13:527–530
  8. Whittier WL, Korbet SM. Renal biopsy: Update. Curr Opin Nephrol Hypertens. 2004;13:661–665
  9. Hergesell O, Felten H, Andrassy K, Kuhn K, Ritz E. Safety of ultrasound-guided percutaneous renal biopsy—Retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant. 1998;13:975–977
  10. Manno C, Strippoli GF, Arnesano L, et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int. 2004;66:1570–1577
  11. Eiro M, Katoh T, Watanabe T. Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol. 2005;9:40–45
  12. Palladini G, Perfetti V, Merlini G. Therapy and management of systemic AL (primary) amyloidosis. Swiss Med Wkly. 2006;136:715–720
  13. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349:583–596
  14. Bergesio F, Ciciani AM, Santostefano M, et al. Renal involvement in systemic amyloidosis—An Italian retrospective study on epidemiological and clinical data at diagnosis. Nephrol Dial Transplant. 2007;22:1608–1618
  15. Kyle RA, Gertz MA. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol. 1995;32:45–59
  16. Pepys MB. Pathogenesis, diagnosis and treatment of systemic amyloidosis. Philos Trans R Soc Lond B Biol Sci. 2001;356:203–210discussion, 210-211
  17. Lachmann HJ, Booth DR, Booth SE, et al. : Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. [see comment] N Engl J Med 346. 2002;346:1786–1791
  18. Yood RA, Skinner M, Rubinow A, Talarico L, Cohen AS. Bleeding manifestations in 100 patients with amyloidosis. JAMA. 1983;249:1322–1324
  19. Mumford AD, O'Donnell J, Gillmore JD, Manning RA, Hawkins PN, Laffan M. Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis. Br J Haematol. 2000;110:454–460
  20. Sucker C, Hetzel GR, Grabensee B, Stockschlaeder M, Scharf RE. Amyloidosis and bleeding: Pathophysiology, diagnosis, and therapy. Am J Kidney Dis. 2006;47:947–955
  21. Choufani EB, Sanchorawala V, Ernst T, et al. Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: Incidence, bleeding manifestations, and response to high-dose chemotherapy. Blood. 2001;97:1885–1887
  22. Enjeti AK, Walsh M, Seldon M. Spontaneous major bleeding in acquired factor X deficiency secondary to AL-amyloidosis. Haemophilia. 2005;11:535–538
  23. Ralls PW, Barakos JA, Kaptein EM, et al. Renal biopsy-related hemorrhage: Frequency and comparison of CT and sonography. J Comput Assist Tomogr. 1987;11:1031–1034
  24. Nicholson ML, Wheatley TJ, Doughman TM, et al. A prospective randomized trial of three different sizes of core-cutting needle for renal transplant biopsy. Kidney Int. 2000;58:390–395
  25. Gazelle GS, Haaga JR, Rowland DY. Effect of needle gauge, level of anticoagulation, and target organ on bleeding associated with aspiration biopsy (Work in progress). Radiology. 1992;183:509–513

 Originally published online as doi:10.1053/j.ajkd.2008.05.022 on July 25, 2008.

PII: S0272-6386(08)00990-6

doi: 10.1053/j.ajkd.2008.05.022

American Journal of Kidney Diseases
Volume 52, Issue 6 , Pages 1079-1083 , December 2008

Article Tools